Pediatric Epilepsy Study in Subjects 1-24 Months

PHASE2CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Epilepsy
Interventions
DRUG

lamotrigine

Trial Locations (70)

1094

GSK Investigational Site, Budapest

1150

GSK Investigational Site, Lisbon

1181

GSK Investigational Site, Capital Federal

1425

GSK Investigational Site, Buenos Aires

3050

GSK Investigational Site, Parkville, Melbourne

3526

GSK Investigational Site, Miskolc

4012

GSK Investigational Site, Debrecen

6720

GSK Investigational Site, Szeged

7623

GSK Investigational Site, Pécs

8034

GSK Investigational Site, Cherry Hill

11501

GSK Investigational Site, Mineola

13210

GSK Investigational Site, Syracuse

14222

GSK Investigational Site, Buffalo

20010

GSK Investigational Site, Washington D.C.

20133

GSK Investigational Site, Milan

22908

GSK Investigational Site, Charlottesville

23298

GSK Investigational Site, Richmond

23507

GSK Investigational Site, Norfolk

27599

GSK Investigational Site, Chapel Hill

27607

GSK Investigational Site, Raleigh

30342

GSK Investigational Site, Atlanta

30912

GSK Investigational Site, Augusta

32207

GSK Investigational Site, Jacksonville

32308

GSK Investigational Site, Tallahassee

32835

GSK Investigational Site, Orlando

33609

GSK Investigational Site, Tampa

35128

GSK Investigational Site, Padua

36693

GSK Investigational Site, Mobile

37212

GSK Investigational Site, Nashville

37813

GSK Investigational Site, Morristown

40138

GSK Investigational Site, Bologna

43205

GSK Investigational Site, Columbus

44106

GSK Investigational Site, Cleveland

46100

GSK Investigational Site, Mantova

51014

GSK Investigational Site, Tartu

51092

GSK Investigational Site, Reims

64108

GSK Investigational Site, Kansas City

65211

GSK Investigational Site, Columbia

72202

GSK Investigational Site, Little Rock

72401

GSK Investigational Site, Jonesboro

75230

GSK Investigational Site, Dallas

76104

GSK Investigational Site, Fort Worth

77030

GSK Investigational Site, Houston

80131

GSK Investigational Site, Napoli

80218

GSK Investigational Site, Denver

84113

GSK Investigational Site, Salt Lake City

85712

GSK Investigational Site, Tucson

90027

GSK Investigational Site, Los Angeles

90095

GSK Investigational Site, Los Angeles

98125

GSK Investigational Site, Messina

11072020

GSK Investigational Site, Beirut

94305-5235

GSK Investigational Site, Stanford

33155-3009

GSK Investigational Site, Miami

40536-0284

GSK Investigational Site, Lexington

55102-2383

GSK Investigational Site, Saint Paul

44308-1062

GSK Investigational Site, Akron

97201-2884

GSK Investigational Site, Portland

97201-2984

GSK Investigational Site, Portland

15213-2583

GSK Investigational Site, Pittsburgh

LV 1004

GSK Investigational Site, Riga

LT-50009

GSK Investigational Site, Kaunas

9713 GZ

GSK Investigational Site, Groningen

3015 GD

GSK Investigational Site, Rotterdam

3584 EA

GSK Investigational Site, Utrecht

3000-075

GSK Investigational Site, Coimbra

4099-001

GSK Investigational Site, Porto

00936

GSK Investigational Site, SanJuan

833 40

GSK Investigational Site, Bratislava

080 01

GSK Investigational Site, Prešov

Unknown

GSK Investigational Site, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY